In particular, correlation analysis between sIL-2R concentrations and the proportion of different immune cell types in COVID-19 patients suggested that sIL-2R may be a negative regulatory factor for T cells, particularly CD8+ T cells, but not CD4+ T cells, NK cells, or B cells [20]. This evidence concerns the gene CD4 and COVID-19.